Global Pharmaceuticals & Biotech Breakout Stocks

AtaiBeckley

Market Cap: US$2.7b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Iovance Biotherapeutics

Market Cap: US$2.2b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

Harbin Pharmaceutical Group

Market Cap: CN¥14.7b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

CareDx

Market Cap: US$2.0b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Xencor

Market Cap: US$1.4b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥4.2b

Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.

Valerio Therapeutics Société anonyme

Market Cap: €438.5m

A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.

Cybin

Market Cap: US$440.7m

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.

China Pharma Holdings

Market Cap: US$328.2m

Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م11.5b

Develops, produces, and sells pharmaceutical products in Egypt.

GlaxoSmithKlineE

Market Cap: ج.م9.2b

Engages in production of pharmaceutical chemicals.

October PharmaE

Market Cap: ج.م5.6b

Manufactures and sells pharmaceutical products in Egypt.

Entera Bio

Market Cap: US$98.1m

A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.

Great Novel Therapeutics Biotech & Medicals

Market Cap: NT$3.0b

Engages in the development of drugs for the treatment of advanced and refractory cancers in Taiwan.

New Green Hemp

Market Cap: US$48.5m

New Green Hemp Inc. cultivates and sells hemp products.

Dyadic International

Market Cap: US$44.1m

A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.

Quratis

Market Cap: ₩32.6b

Engages in developing vaccines in South Korea.

Numinus Wellness

Market Cap: US$15.4m

Provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States.

Stem Cells Spin

Market Cap: zł21.3m

Operates as a biotechnology company in Poland.

Blueberries Medical

Market Cap: CA$7.4m

A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.

Panacea Life Sciences Holdings

Market Cap: US$4.5m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

BPH Global

Market Cap: AU$4.7m

Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.

Delex Healthcare Group

Market Cap: US$3.2m

Engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.

CBD Life Sciences

Market Cap: US$1.5m

Engages in the development and marketing a line of cannabidiol based organic products.

Innovation Pharmaceuticals

Market Cap: US$1.1m

A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.

Maple Leaf Green World

Market Cap: US$589.6k

Does not have significant operations.

co.don

Market Cap: €427.6k

Does not have significant operations.

Greater Cannabis Company

Market Cap: US$255.2k

Engages in the development and commercialization of cannabinoid therapeutics.

NanoSphere Health Sciences

Market Cap: CA$308.3k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

GB Sciences

Market Cap: US$158.8k

A plant-based research and biopharmaceutical drug development company.

Myrexis

Market Cap: US$27.6k

Focuses on identifying, evaluating, and making financial investments in life sciences assets.